Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Hematology
Description:
Welcome to today’s episode. Persistent blood abnormalities, such as ongoing anemia or unusual white cell counts, require careful evaluation by a hematologist. The process begins with a detailed medical history and physical examination, followed by targeted blood tests like complete blood counts and peripheral smears. If needed, further tests such as bone marrow biopsies or genetic studies may be ordered to identify the root cause. Throughout this process, hematologists consider both common and rare conditions, ensuring nothing is overlooked. Early and accurate diagnosis is key to guiding effective treatment and improving patient outcomes. If you or someone you know has unexplained blood test results, consulting a hematologist is an important next step. Thank you for listening.
See More Webinars @ Hidoc Webinars
1.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
2.
These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?
3.
Novel radiotracer identifies biomarker for triple-negative breast cancer
4.
Should the UK introduce targeted prostate cancer screening? The case for and against
5.
Unlocking the potential of targeted therapies for multiple myeloma
1.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
2.
Cemiplimab: A Revolutionary Drug For Treating Cancer
3.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
4.
Unlocking The Causes And Risk Factors Of Breast Cancer
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge